Indian secondaries: getting across the line

A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.

ByRod James

23 November 2018•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Featured Asia-Pacific

Indian secondaries: getting across the line

British International Investment

Coller Capital

Capital Dynamics

Capital Square Partners

TPG NewQuest

Related articles